REPROCELL USA Receives Maryland Stem Cell Research Fund Grant for New CDMO

Oct 28, 2025
REPROCELL USA has received funding from the Maryland Stem Cell Research Fund to develop a GMP-grade Contract Development and Manufacturing Organization in Maryland, expanding its stem cell manufacturing capabilities.

REPROCELL USA has received funding from the Maryland Stem Cell Research Fund (MSCRF) through the Manufacturing Assistance Grant Program, announced in a press release. The grant, part of MSCRF’s July 2025 funding cycle, supports the establishment of a Contract Development and Manufacturing Organization (CDMO) in Maryland.

The project, titled “Development of a Centralized (GMP) Contract Development and Manufacturing Organization (CDMO) and iGRP manufacturing,” will include a clean room for large-scale GMP-grade cell therapy product production. This facility will enable REPROCELL to provide two GMP technologies under one roof.

The new CDMO will expand REPROCELL’s capacity to produce working cell banks for cell therapy products, GMP-grade differentiation, gene editing services, and large-scale mesenchymal stem cells (MSC) generated from human induced pluripotent stem cells (hiPSC). The funding is structured as a 1:1 match, with REPROCELL matching the MSCRF contribution dollar for dollar.

In 2024, MSCRF also provided a grant to enhance REPROCELL’s Cytocentric Xvivo System Model 2 from BioSpherix, a closed GMP system for master cell bank manufacturing.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.